Items where authors include "Sampson, J."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Dark, P., Hossain, A., McAuley, D.F. et al. (543 more authors) (2025) Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. Journal of the American Medical Association (JAMA), 333 (8). pp. 682-693. ISSN 0098-7484

Shelford, J., Burgess, S., Rostkova, E. et al. (11 more authors) (2025) Structural characterization and inhibition of the interaction between ch-TOG and TACC3. Journal of Cell Biology. ISSN 0021-9525 (In Press)

Sampson, J., Ju, H., Zhang, N. et al. (3 more authors) (2024) Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer. Cell Death and Disease, 15. 912. ISSN 2041-4889

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Kim, M., Ju, H., Song, J. et al. (3 more authors) (2024) HER3 overexpression: a predictive marker for poor prognosis in advanced ALK-positive non-small cell lung cancer treated with ALK inhibitors. Translational Lung Cancer Research Journal, 13 (2). pp. 321-333. ISSN 2218-6751

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Bayliss, R. orcid.org/0000-0003-0604-2773, Sarnowska, E., Yeoh, S. et al. (1 more author) (2023) ALKing the flames of lung cancer immunosensitivity. Molecular Oncology, 17 (11). pp. 2218-2220. ISSN 1574-7891

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836

McRae, J.F., Clayton, S., Fitzgerald, T.W. et al. (299 more authors) (2017) Prevalence and architecture of de novo mutations in developmental disorders. Nature, 542 (7642). pp. 433-438. ISSN 0028-0836

Reifarth, R., Altstadt, S., Göbel, K. et al. (317 more authors) (2016) Nuclear astrophysics with radioactive ions at FAIR. Journal of Physics: Conference Series. 012044. ISSN 1742-6596

Berndt, S.I., Skibola, C.F., Joseph, V. et al. (127 more authors) (2013) Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nature Genetics, 45 (8). pp. 868-876. ISSN 1061-4036